YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotechnology startup Wugen Inc. raised $172 million in a funding round.
The company plans to use the funds to advance clinical development of its cancer-fighting therapies, the St. Louis Business Journal reports.
The startup has raised more than $200 million to date.
Read more from the St. Louis Business Journal.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.